Literature DB >> 4141942

Immunological studies on liver diseases in the Mongolian People's Republic.

M A Akhmeteli, V I Vasil'Eva, N Dordzgotov, N Namdava, K S Cernov, N B Sipaceva.   

Abstract

The sera of 445 persons, mainly patients with various liver diseases, were examined for alpha-fetoprotein (AFP) and hepatitis B antigens (HB Ag) and antibodies (HB Ab). The presence of AFP was detected in 9 sera by agar-gel precipitation and in 22 additional sera by the more sensitive aggregate haemagglutination technique. HB Ag proved to be present in 74 sera and HB Ab was present in 34 sera. Hepatitis B antigen was present more frequently (42%) in sera containing alpha-fetoprotein than in sera that did not contain it (14.7%). The food habits of the population investigated were also studied.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4141942      PMCID： PMC2481138     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  6 in total

1.  Australia antigen in Singapore Chinese patients with hepatocellular carcinoma and comparison groups: influence of technique sensitivity on differential frequencies.

Authors:  M J Simons; E H Yap; M Yu; K Shanmugaratnam
Journal:  Int J Cancer       Date:  1972-09-15       Impact factor: 7.396

2.  [Evaluation of the use of highly sensitive methods of determining alpha-fetoprotein for the diagnosis of hepatocellular cancer and teratoblastoma].

Authors:  G I Abelev; V S Tsvetkov; T I Biriulina; D A El'gort; A M Olovnikov
Journal:  Biull Eksp Biol Med       Date:  1971-04

3.  Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease.

Authors:  E Ruoslahti; M Seppälä
Journal:  Lancet       Date:  1972-08-05       Impact factor: 79.321

4.  [Detection of embryonic alpha-globulin in the serum of patients with various forms of cancer by the aggregate-hemagglutination method].

Authors:  A M Olovnikov; V S Tsvetkov
Journal:  Biull Eksp Biol Med       Date:  1969-12

5.  S.H. antigen and chronic liver disease.

Authors:  A M Prince; L Leblanc; K Krohn; R Masseyeff; M E Alpert
Journal:  Lancet       Date:  1970-10-03       Impact factor: 79.321

6.  Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.

Authors:  C L Vogel; P P Anthony; N Mody; L F Barker
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.